TegoScience Inc (191420) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.066x

Based on the latest financial reports, TegoScience Inc (191420) has a cash flow conversion efficiency ratio of -0.066x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.18 Billion ≈ $-2.15 Million USD) by net assets (₩48.32 Billion ≈ $32.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can TegoScience Inc fund operations to measure how many days the company can operate on defensive assets alone.

TegoScience Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how TegoScience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

TegoScience Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of TegoScience Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Beshom Holdings Bhd KLSE:7668	0.033x
SIFCO Industries Inc NYSE MKT:SIF	0.209x
Connexa Sports Technologies Inc. NASDAQ:YYAI	-0.186x
NH SPAC 5 KQ:215790	-0.019x
Econpile Holdings Bhd KLSE:5253	0.006x
LFE Corporation Bhd KLSE:7170	0.026x
Timberwell Bhd KLSE:7854	0.017x
Thai Textile Industry Public Company Limited BK:TTI	0.013x

Annual Cash Flow Conversion Efficiency for TegoScience Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of TegoScience Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of TegoScience Inc.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩50.33 Billion ≈ $34.11 Million	₩-3.07 Billion ≈ $-2.08 Million	-0.061x	-162.02%
2024-12-31	₩49.86 Billion ≈ $33.79 Million	₩-1.16 Billion ≈ $-785.84K	-0.023x	-35.59%
2023-12-31	₩46.33 Billion ≈ $31.39 Million	₩-794.61 Million ≈ $-538.49K	-0.017x	-180.12%
2022-12-31	₩48.60 Billion ≈ $32.93 Million	₩1.04 Billion ≈ $705.01K	0.021x	+126.95%
2021-12-31	₩48.47 Billion ≈ $32.85 Million	₩457.25 Million ≈ $309.87K	0.009x	-63.89%
2020-12-31	₩48.99 Billion ≈ $33.20 Million	₩1.28 Billion ≈ $867.16K	0.026x	+2916.76%
2019-12-31	₩47.82 Billion ≈ $32.41 Million	₩41.40 Million ≈ $28.06K	0.001x	-95.15%
2018-12-31	₩46.68 Billion ≈ $31.63 Million	₩833.88 Million ≈ $565.11K	0.018x	-77.74%
2017-12-31	₩35.71 Billion ≈ $24.20 Million	₩2.87 Billion ≈ $1.94 Million	0.080x	-11.57%
2016-12-31	₩25.98 Billion ≈ $17.61 Million	₩2.36 Billion ≈ $1.60 Million	0.091x	-13.13%
2015-12-31	₩25.21 Billion ≈ $17.08 Million	₩2.63 Billion ≈ $1.78 Million	0.104x	--

About TegoScience Inc

KQ:191420 Korea Pharmaceuticals

Market Cap

$40.93 Million

₩60.40 Billion KRW

Market Cap Rank

#22681 Global

#1460 in Korea

Share Price

₩7480.00

Change (1 day)

-5.20%

52-Week Range

₩7480.00 - ₩18970.00

All Time High

₩71600.00